Live cell immunogold labelling of RNA polymerase II by Orlov, I. (Igor) et al.
Live cell immunogold labelling of RNA
polymerase II
Igor Orlov1, Andreas Schertel2, Guy Zuber3, Bruno Klaholz1, Robert Drillien1, Etienne Weiss4,
Patrick Schultz1 & Danie`le Spehner1
1Department of Integrated Structural Biology, IGBMC (Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellulaire) INSERM, U964;
CNRS/Strasbourg University, UMR7104 1, rue Laurent Fries, BP10142 67404 Illkirch, France, 2Carl Zeiss Microscopy GmbH,
Training, Application and Support Center (TASC), Carl-Zeiss-Straße 22, D-73447 Oberkochen, Germany, 3LCAMB, UMR 7199,
CNRS/Strasbourg University, Faculty of Pharmacy, 74 route du Rhin, 67401 Illkirch, France, 4LBSC, UMR 7242, Institut de
Recherche de l’Ecole de Biotechnologie de Strasbourg, Strasbourg University, 300 Boulevard Se´bastien Brandt, BP 10413, 67412
Illkirch, France.
Labeling nuclear proteins with electron dense probes in living cells has been a major challenge due to their
inability to penetrate into nuclei. We developed a lipid-based approach for delivering antibodies coupled to
0.8 nm ultrasmall gold particles into the nucleus to label RNA polymerase II. Focussed Ion Beam slicing
coupled to Scanning Electron Microscopy (FIB/SEM) enabled visualization of entire cells with probe
localization accuracy in the 10 nm range.
T
he intracellular localization and dynamics of proteins involved in cellular processes aremost often studied in
living cells at light microscopy resolution (,300–500 nm) by monitoring proteins fused to fluorescent tags.
The limited spatial definition and the fluorescence-restricted information content of lightmicroscopy can be
complemented by electron microscopy (EM) which expands resolution to molecular dimensions and uncovers
the ultracellular context of the protein of interest. Macromolecular detection in EM relies on labeling with
electron-dense particles and the most successful method conjugates primary or secondary antibodies to gold
particles that provide high contrast and easily recognizable shape1. In most experiments the labeling step is
performed after specimen embedding and the antibodies are incubated either with fixed resin-embedded cell
sections2 or sucrose embedded cryosections3. Poor epitope accessibility within cell sections and the requirement
of fixatives leading to denaturation, even when reduced in the case of sucrose embedding, restrict detection of rare
epitopes. Pre-embedding methods were developed to label the macromolecules before processing the cells for
EM4,5 but such in situ immunolabelling experiments required chemical fixation and cell permeabilization, which
affect the structural integrity of the sample. Furthermore the gold-conjugated antibodies failed to cross the
nuclear envelop and reach their targets in the cell nucleus.
Here we have developed a method to internalize immunogold labels into living cells and allow their nuclear
import. Physiological internalization is generally restricted to specialized cell types involved in macropinocytosis
or receptor mediated endocytosis6. For more general use we employed lipid-based protein delivery agents
compatible with cell viability to internalize the probes7. The cationic lipid dioctadecylamidoglycine spermine
(DOGS) was first described as an effective gene transfection reagent8 and such lipids were later used to deliver
antibodies into the cytoplasm of mammalian cells9,10. Assays with E6 oncoprotein neutralizing antibodies have
demonstrated that the lipid vehicles protect the antibodies from degradation in the endosomal/lysosomal com-
partment since they inhibit E6 activity in vivo11. Antibodies do not diffuse freely into the nucleus and fluorescein-
labelled anti tubulin antibodies delivered by lipid vehicles into HeLa cells remain cytoplasmic as expected for
molecules devoid of Nuclear Localization Signals12 (Fig. S1). However antibodies directed against nuclear targets
such as RNA polymerase II (RNAPII) can be imported into the nucleus presumably because they recognize their
target in the cytoplasm and are transported into the nucleus by a piggyback mechanism.
Results
To label RNAPII with electron dense probes suitable for EM localization studies we employed a monoclonal
antibody directed against the C-terminal domain (CTD) of its largest subunit (aRNAPII, clone 7C2). This
antibody was characterized previously for its ability to label RNAPII in vivo in cultured HeLa cells12. It was here
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mercially available lipid-based antibody delivery system. After 8 h
incubation, the aRNAIPII-gold6 was mostly located in big patches
within cytoplasmic vesicles and at the periphery of the cell mem-
brane (Fig. 1A). Control cells without antibody delivery did not
uptake the aRNAPII-gold6 particles. In sharp contrast to the fluor-
escent probe, aRNAPII-gold6 could not be detected in the nucleus
indicating that the internalized probe could not cross the nuclear
envelope.
To determine whether the size of the colloidal gold particles could
affect nuclear transport, the aRNAPII IgG was conjugated to 0.8 nm
ultrasmall colloidal gold (aRNAPII-US)13. The reduced size of the
gold particle will affect mass, charge and volume of the final marker
since several 15 nm sized antibodies can bind to a single 6 nm gold
particle while it is generally believed that one or twoUS gold particles
can bind to each IgG molecule. The freshly prepared aRNAPII-US
was delivered into HeLa cells as described above and after 8 h
incubation the cells were processed for Transmission Electron
Microscopy (TEM) observation. Due to their small size, the US gold
particles were amplified to be visible at the TEM level. The obser-
vation of 100 nm thick cell sections readily disclosed the amplified
gold particles which were present in the cytoplasm and enriched in
the nucleus (Fig. 1B). The cytoplasmic aRNAPII-US particles were
not found in vesicles indicating that they are releasedmore efficiently
into the cytosol than aRNAPII-gold6. Most importantly, the US-
coupled aRNAPII was efficiently imported into the nucleus where
it accumulated similarly to the control fluorescent antibody12. We
further reduced the size of the probe by conjugating the US gold to
Fab fragments (aRNAPII-Fab-US). When used in the same condi-
tions as the aRNAPII-USG, the smaller aRNAPII-Fab-US showed
an improved cellular uptake and was similarly enriched in the nuc-
leus (Fig. 1C andD, Fig. S2). Additional experiments were performed
by conjugating aRNAPII to a solution of gold particles with a size
ranging between 2 and 5 nm. As for the 6 nm gold particles, these
experiments revealed most of the gold conjugates as aggregates in
lipids vesicles (Fig. S3). Altogether these observations indicate that
antibodies or Fab fragments conjugated to 0.8 nm gold particles are
efficiently delivered into living cells, can be imported into the nucleus
and detected by TEM after amplification.
The FIB/SEM technology was used to map the distribution of
RNAPII in the entire nuclear volume. In this method, the focused
ion beam (FIB) mills away a thin section of the samples while the
scanning electron beam (SEM) is used to image the newly created cell
cross-section14. The sequential use and iteration of these two pro-
cesses opens the possibility to image large areas at high spatial reso-
lution and over a depth of several microns. To date FIB/SEM imaging
has not been coupled with in situ live cell labeling and little is known
about the visualization of gold particles15. The combination of these
two methods offers the unique possibility to quantify the labeled
nuclear proteins within the whole nucleus. SEM images 30 by
20 mm in size of HeLa cells labeled with aRNAPII-US or
aRNAPII-Fab-US were recorded with an image pixel size of 5 nm.
Sequential FIBmilling removed 25 nm thick slices and a stack of 400
images was recorded to yield a volume 10 mm in depth. The amp-
lified gold particles were readily detected in the SEM images
(Fig. 2A–B). The high contrast obtained possibly reflects the absence
of superposition effects with other cellular structures. At the low SEM
acceleration potential used the collected back scattered electrons
have a penetration depth of 5–10 nm for osmium treated cells as
modeled by Monte Carlo simulations16,17 and therefore only struc-
tures close to the FIB-milled surface are imaged.
In order to quantify the labeling it is crucial to know which pro-
portion of gold particles is detected within the milled-away 25 nm
thick slices. Depending on their depth with respect to the imaged
surface the bead size and contrast may be variable with the risk for
some particles to bemissed. To address this question, the thickness of
the FIB slices was reduced to 5 nm in order to trace the same particle
on successive views (Fig. 2C). In these conditions the same particle
was detected on average on 4 consecutive sections consistent with its
size of about 20 nm.We therefore expected to miss about 20% of the
particles bymilling 25 nm slices.Moreover, themilling of 5 nm thick
slices positions the gold particle with high precision since its central
coordinates can be calculated by interpolation at sub-pixel resolution
in x, y and z directions. A total of 100 successive sections (roughly
2.5 mm) were analyzed for the aRNAPII-US and the aRNAPII-Fab-
US markers. The amplified gold particles were counted, the labeling
density was determined in different cellular compartments (Table 1),
and the particle distribution was represented in the 3-D cellular
context (Fig. 2D, Fig. S4 andMovie1). The uptake efficiency as mon-
itored by the average cellular density of particles was found to be two
fold higher for the Fab-US (16.8 particles/mm3) than for the IgG-US
(4.9 particles/mm3) indicating again that smaller markers enter better
into the cell. Consistently with the behavior of the fluorescently
labeled aRNAPII IgG and the TEM observations, 84% and 79% of
the amplified gold particles were found in the nucleus; and the label-
ing density was 5.0 times and 7.9 times higher in the nucleus than in
the cytoplasm for the Fab-US and for the IgG-US, respectively. This
indicates a strong enrichment of the gold particles in the nucleus and
an active nuclear translocation of the conjugated Fab or IgG mole-
cules. The aRNAPII-Fab-US and aRNAPII-IgG-US particles were
mostly localized in the euchromatin region of the nucleus which is
consistent with the distribution of active transcription in the less
densely packed chromatin regions of the nucleus. Moreover the nuc-
leolus showed a 3.2 fold lower aRNAPII-Fab-US labeling density
which is expected since no RNAPII transcription occurs in this nuc-
lear compartment. This depletion was less pronounced in the case of
the IgG-based marker.
Discussion
Transcription is believed to occur in specialized foci locally enriched
in RNAPII molecules18 and recent data suggest that this dynamic
clustering is regulated by external cellular signals19. The RNAPII
Figure 1 | Transmission electron micrographs of HeLa cell sections
labeled in vivo with antibodies directed against RNA polymerase II and
coupled to gold beads. (A) Antibodies coupled to 6 nm colloidal gold
particles are found aggregated in large cytoplasmic vesicles. (B) Antibodies
coupled to 0.8 nm gold particles are detected as individual spots after silver
enhancement in the cytoplasm and are enriched in the nucleus. (C)
Distribution of the amplified gold particles coupled to IgG molecules
directed against RNApolymerase II. (D)Distribution of the amplified gold
particles coupled to Fab fragments directed against RNA polymerase II.
The bar represents 1 mm in (A), 0.2 mm in (B) and 0.6 mm in (C) and (D).
www.nature.com/scientificreports
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molecules were however found distributed in the whole nucleus. Our
data is consistent with an overall distribution of RNAPII in the whole
nuclear volume but does not reveal significant clustering of the
enzymes since the vast majority of the gold particles are separated
by more than 200 nm. Occasionally two gold particles can be found
in close proximity and we cannot exclude that this corresponds to
two antibodies bound to the same RNA polymerase since the 7C2
antibody recognizes both hyperphosphorylated and unphosphory-
lated forms of the 52 heptapeptide repeats found in the CTD. In order
to estimate the fraction of labelled RNAPII molecules we multiplied
the labelling density obtained for the best probe (23.8 aRNAPII-Fab-
US particles per mm3, Table 1) by the volume of the HeLa cell nucleus
(with a diameter of,14 mm the nucleus occupies a volume of about
1400 mm3). A total of 33.000 RNAPII molecules are therefore labeled
in our conditions, which corresponds to about 10% of the estimated
enzymes per cell nuclei17. With the currently achieved labeling effi-
ciency it is therefore unlikely to reveal clustered RNAPII molecules.
Post-embedding immunogold labeling experiments using the 7C2
Figure 2 | FIB/SEM visualization of amplified gold particles. (A) Scanning Electron Micrograph of a HeLa cell labeled in vivo with RNA polymerase II-
specific Fab fragments conjugated to ultrasmall gold particles. The nuclear (nuc) and cytoplasmic (cyt) compartments are indicated. The bar represents
0.5 mm. (B) Enlargement of the area delineated in (A) to show the amplified gold particles highlighted arrowheads circles. (C) Gallery of 4 amplified gold
particles (columns) imaged by SEM on successive 5 nm thick FIB sections (D) Three-dimensional reconstruction of a series of FIB/SEM images
representing the whole nucleus. The electron dense nuclear envelope and the nucleolus are represented by blue isodensity surfaces. The amplified gold
particles are represented in yellow. Dense heterochromatin domains are represented in red.
Table 1 | Quantification of the gold particles in different cellular compartments
aRNAPII-Fab-US aRNAPII-IgG-US
number volume (mm3) density number volume mm3 density
Cytoplasm 196 41.9 4.7 124 101.9 1.2
Whole nucleus 1717 71.9 23.8 804 86.8 9.3
Nucleus without nucleoli 1699 69.5 24.4 757 80.1 9.5
Nucleoli 18 2.4 7.5 47 6.7 7.0
total 1913 113.8 16.8 928 188.7 4.9
www.nature.com/scientificreports
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antibody were previously performed on Lowicryl sections of HeLa
cells infected by type 1 herpes simplex virus and revealed that
RNAPII were associated with viral gene transcription factories and
clusters of interchromatin granules20. Discrete nuclear structures
such as perichromatin fibrils or interchromatin granules previously
identified as sites of RNA transcription and maturation21,22 were not
specifically labeled with our pre-embedding immunogold labeling
method. Additional experiments are needed to assess whether the
hypophosphorylated RNAPII labeled in the cytoplasm can still be
recruited to gene promoters and phosphorylated to be converted into
a transcriptionally active state.
In summary we demonstrate that lipid-based delivery systems
allow the efficient internalization of electron dense markers coupled
to antibodies. Their fate depends on the size of the gold particle and
only antibodies coupled to 0.8 nm gold particles are delivered into
the cytoplasm and are not sequestered in membrane structures. The
FIB/SEM visualization allows a clear detection and quantification of
the amplified gold particles in the whole nucleus. The probes and the
delivery system are compatible with cell viability and the localization
of the RNAPII as revealed by the markers is consistent with the
expected distribution of the enzyme. This new method holds pro-
mises for high resolution in situ labeling of cellular proteins and for
cryo electron tomography.
Methods
Antibody probes. We used a monoclonal antibody directed against the C-terminal
domain of the largest subunit of RNA polymerase II (clone 7C2)23. The
immunopurified antibody was either fluorescently labeled using fluorescein
isothiocyanate (FITC) using standard methods or coupled to 6 nm gold colloid
particles1. To generate Fab fragments 1 mg of immunopurified 7C2 antibody was
cleaved into Fab fragments by immobilized Ficin and purified using a protein A
column (Pierce Biotechnology). The IgG and the Fab were coupled to US-colloı¨dal
gold particles by the manufacturer (US-colloidal gold, Aurion, The Netherlands).
Antibody delivery. Ten ml of purified 7C2 antibodies or of the different 7C2 gold
conjugates at a protein concentration of 100 mg/ml were incubated for 10 min at room
temperature with 3 ml of a lipid based formulation allowing the delivery of functional
antibodies into living cells (Ab-DeliverINTM, Ozbiosciences). The volume was completed
to 300 ml. 200 ml of the formed lipoplexes were added into the culture media of adherent
HeLa cells which were 50–70% confluent at the time of the delivery. The cells were
incubated for 4, 8, 12 or 24 hours with the protein delivery agent and subsequently washed
with PBS before being fixed with 2.5% glutaraldehyde diluted in PBS for at least 1 hour.
After several washes with water, the silver enhancement was done according to the
manufacturer’s protocol (SE-EM, Aurion, The Netherlands) and washed again with water.
Specimen preparation andTransmissionElectronMicroscopy.The glutaraldehyde
crosslinked cells were processed for electron microscopy using standard protocols.
Briefly, cells were fixed and contrasted with 0.5% osmium for 20 min then contrasted
with 2% uranyl acetate before being dehydrated in increasing concentrations of
alcohol and flat embedded in epon. The resin embedded cells were sectioned into
100 nm thick slices that were deposited on an electron microscopy grid and observed
in a Transmission Electron Microscope (Tecnai F20 G2, FEI) equipped with a field
emission gun operating at 200 kV at a magnification of 11.500 x, on a 20483 2048
CCD camera (Ultrascan 1000, Gatan Inc., Pleasanton) with a final pixel spacing on
the specimen of 0.92 nm. Adjacent regions of the specimen were recorded and the
images were stitched together to form montages of 5 3 5 frames by using the Serial
EM software24.
Scanning Electron microscopy and Focused Ion Beam milling. Focused Ion Beam
milling and Scanning Electron Microscopy observations were performed using a
dedicated instrument (Auriga 60, Carl Zeiss Microscopy GmbH, Oberkochen). For
3D reconstruction 25 nm thick slices of the resin embedded sample were removed by
FIB milling and the freshly exposed cross-section was imaged with a lateral pixel size
of 5 nm in a serial manner. For FIBmilling the probe current was set to 2 nA at 30 kV
acceleration potential. The FIB-milled cross-section width was of 30 mm by 20 mm
and the milling depth was 10 mm. The image store resolution was 2048 pixel3 1536
pixel resulting in an image width of about 10 mm and in an image height of about
7.5 mm. For noise reduction line averaging with line averaging count number N5 11
and scan speed 4 was used. The resin block was glued on an aluminum stub using
silver paint (Silver dag 1415, Plano GmbH, Wetzlar). First all sidewalls besides the
block face were covered by silver paint and then the block face was sputter-coated
with a few nanometer thick metal film to avoid any charging of the resin. Prior to
serial cross-sectioning and imaging no protection layer besides the sputter coating
was deposited. The SEM acceleration voltage was set to 1.5 kV, the SEM aperture was
60 mm and high current mode was turned on. For imaging the Energy selective Back-
scattered electron (EsB) detector was used with a retarding EsB grid voltage of 1425
volts. The SEM imaging took about 29 sec and the milling of each slice about 4 sec.
The acquired data cube consists of more than 400 single slice images. The grey level
scale was inverted in order to obtain a TEM like image.
Image processing and segmentation. A stack containing 300 images 2048 by 1536
pixels in size was created after inverting and normalizing the image intensities. A
cropped region 1024 by 1024 pixels in size from the center of the stack was aligned
using the ‘‘multistack Reg Fix’’ plugin in Fiji25. Segmentation and 3-D rendering of the
density map were performed using the Seg2D software (http://www.seg3d.org). The
segmentation was done in a semi-automatic mode by thresholding the density map
and tracing continuous grey levels. Particle detection was done by setting a density
threshold based on the high contrast of the amplified gold particles, while particle
counting was performed in Fiji.
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